Evidence map›Paper›PMID 27125198›Full record

ArticleToxicology and applied pharmacology2016

Mustard vesicants alter expression of the endocannabinoid system in mouse skin.

Irene M Wohlman, Gabriella M Composto, Diane E Heck, Ned D Heindel, C Jeffrey Lacey, Christophe D Guillon, Robert P Casillas, Claire R Croutch, Donald R Gerecke, Debra L Laskin and 2 more

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Skin on Drugs: Psychotropic Compounds in Cutaneous Biology.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Irene M WohlmanDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.
Gabriella M CompostoDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.
Diane E HeckEnvironmental Health Science, New York Medical College, Valhalla, NY, United States.
Ned D HeindelDepartment of Chemistry, Lehigh University, Bethlehem, PA, United States.
C Jeffrey LaceyDepartment of Chemistry, Lehigh University, Bethlehem, PA, United States.
Christophe D GuillonDepartment of Chemistry, Lehigh University, Bethlehem, PA, United States.
Robert P CasillasMRIGlobal, Kansas City, MO, United States.
Claire R CroutchMRIGlobal, Kansas City, MO, United States.
Donald R GereckeDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.
Debra L LaskinDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.
Laurie B JosephDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.
Jeffrey D LaskinEnvironmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ, United States. Electronic address: jlaskin@eohsi.rutgers.edu.
Rutgers, The State University of New Jersey · USLehigh University · USMRIGlobal · USEnvironmental and Occupational Health Sciences Institute · USNew York Medical College · US

Funding

UMDNJ/Rutgers University CounterACT Research Center of ExcellenceU54AR055073 · NIAMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI HECK, DIANE E · 2006 to 2024
$71.4M
Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ROBERT John LAUMBACH · 1988 to 2026
$47.4M
TRAINING IN EVIRONMENTAL TOXICOLOGYT32ES007148 · NIEHS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI Lauren M Aleksunes · 1987 to 2026
$11.4M
ACTIVATED MACROPHAGES AND OZONE TOXICITYR01ES004738 · NIEHS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI Debra L Laskin · 1989 to 2026
$9.0M
Developing Drugs to Mitigate Parathion IntoxicationU01NS079249 · NINDS · RBHS-SCHOOL OF PUBLIC HEALTH · PI LASKIN, JEFFREY D, RICHARDSON, JASON R · 2013 to 2017
$4.0M
NIAMS NIH HHS U54 AR055073NIEHS NIH HHS P30 ES005022NIEHS NIH HHS R01 ES004738NIEHS NIH HHS T32 ES007148NINDS NIH HHS U01 NS079249
6 · The paper itself

Abstract

Vesicants including sulfur mustard (SM) and nitrogen mustard (NM) are bifunctional alkylating agents that cause skin inflammation, edema and blistering. This is associated with alterations in keratinocyte growth and differentiation. Endogenous cannabinoids, including N-arachidonoylethanolamine (anandamide, AEA) and 2-arachidonoyl glycerol (2-AG), are important in regulating inflammation, keratinocyte proliferation and wound healing. Their activity is mediated by binding to cannabinoid receptors 1 and 2 (CB1 and CB2), as well as peroxisome proliferator-activated receptor alpha (PPARα). Levels of endocannabinoids are regulated by fatty acid amide hydrolase (FAAH). We found that CB1, CB2, PPARα and FAAH were all constitutively expressed in mouse epidermis and dermal appendages. Topical administration of NM or SM, at concentrations that induce tissue injury, resulted in upregulation of FAAH, CB1, CB2 and PPARα, a response that persisted throughout the wound healing process. Inhibitors of FAAH including a novel class of vanillyl alcohol carbamates were found to be highly effective in suppressing vesicant-induced inflammation in mouse skin. Taken together, these data indicate that the endocannabinoid system is important in regulating skin homeostasis and that inhibitors of FAAH may be useful as medical countermeasures against vesicants.

Indexed as

Alkylating AgentsAmidohydrolasesAnimalsChemical Warfare AgentsFatty Acid Amide HydrolasesFemaleIrritantsMaleMechlorethamineMiceMice, HairlessMustard GasPPAR alphaReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2SkinAlkylating AgentsAmidohydrolasesChemical Warfare AgentsFatty Acid Amide HydrolasesIrritantsMechlorethamineMustard GasPPAR alphaReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2EndocannabinoidsEpidermisFAAHInflammationSulfur mustardVesicants

Identifiers

PMID27125198
PMCPMC4947375
OpenAlexW2344901885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.